Novo Nordisk partners with OpenAI as AI drug discovery hopes mount (opens in new tab)
The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.
Read the original articleThe partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.
Read the original article